Compare Marathon Petroleum Corp (MPC) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs TG Therapeutics Inc — how do they compare? Marathon Petroleum Corp trades at $319.23 (market cap $92.05B), while TG Therapeutics Inc trades at $54 (market cap $8.26B). The key difference: Marathon Petroleum Corp is far larger — about 11.1× TG Therapeutics Inc's market cap, and Marathon Petroleum Corp pays a 1.24% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MPC | TGTX | |
|---|---|---|
Market Cap | $92.05B | $8.26B |
Sector | Energy | Health |
52-Week High | $315.31 | $59.06 |
52-Week Low | $158.59 | $26.39 |
Enterprise Value | $124.23B | $8.50B |
Dividend Yield | 1.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Petroleum (MPC) trades at $319.76, up 2.29% with strong technical momentum and bullish moving average signals. The stock shows robust fundamentals with a 27.92% ROE and 3.42% net margin, though revenue has declined from $177.5B in 2022 to $132.7B in 2025. Recent earnings beat expectations in Q4 2025 and Q1 2026, while analyst consensus remains strongly bullish with 25 buy ratings and a $292.70 price target. The company benefits from strong refining margins and strategic upgrades driving profitability.
MPC presents a compelling investment case with strong profitability metrics and positive analyst sentiment, though investors should monitor declining revenue trends and elevated debt levels. The stock's current price near resistance levels suggests potential for consolidation, while refining margin advantages and limited Russian capacity create tailwinds. Key risks include oil price volatility and macroeconomic pressures on energy demand.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
